As of 2024-12-13, the Intrinsic Value of TCR2 Therapeutics Inc (TCRR) is -20.77 USD. This TCRR valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.48 USD, the upside of TCR2 Therapeutics Inc is -1,503.43%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-20.77 - -20.77	-20.77	-1,503.43%
P/E	(47.02) - (79.43)	(75.40)	-5194.4%
DDM - Stable	(27.51) - (85.16)	(56.34)	-3906.5%
DDM - Multi	(21.75) - (54.74)	(31.40)	-2221.8%